Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02581488 · ClinicalTrials.gov registry record · Phase 4
Use of Santyl in Diabetic Foot Ulcers
A Phase 4 study, sponsored by Smith & Nephew.
- Completed
- Registry status
- Phase 4
- Development phase
- 102
- Enrollment target
NCT02581488 is a Phase 4 study that has completed, run by Smith & Nephew. The registered enrollment target is 102 participants.
The verdict
NCT02581488, a Phase 4 study, has completed, sponsored by Smith & Nephew.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 102 participants
- Enrollment target
Study Summary
This study is designed to test the hypothesis that daily treatment of diabetic foot ulcers with an enzymatic debriding agent, SANTYL, for up to 6 weeks will result in more rapid decrease in ulcer area than diabetic foot ulcers treated with a topical treatment containing silver. After meeting study criteria, participants will be randomly assigned to apply SANTYL or a topical treatment containing silver to their to foot ulcer for up to 6 weeks. At the end of 6 weeks, participants will be followed for an additional 4 weeks to examine the outcome of the study treatment.
Interventions
- BIOLOGICAL Santyl
- OTHER Product containing silver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2015-10 |
| Est. Completion | 2017-01-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02581488
The ClinicalTrials.gov registry entry for NCT02581488 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Smith & Nephew, which has 72 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Santyl is the first listed.
NCT02581488 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02581488 about?
NCT02581488 is a clinical study titled "Use of Santyl in Diabetic Foot Ulcers". This study is designed to test the hypothesis that daily treatment of diabetic foot ulcers with an enzymatic debriding agent, SANTYL, for up to 6 weeks will result in more rapid decrease in ulcer area than diabetic foot ulcers treated with a topical treatment containing silver. After meeting study c...
What is the current status of trial NCT02581488?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 102 participants. The study started on 2015-10. Estimated completion is 2017-01-12.
What interventions are being tested in trial NCT02581488?
The interventions under investigation include: Santyl (BIOLOGICAL), Product containing silver (OTHER).
Who is sponsoring clinical trial NCT02581488?
This trial is sponsored by Smith & Nephew, which has 72 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.